Chemours (NYSE: CC) reported Q1 EPS of $1.41, $0.19 better than the analyst estimate of $1.22. Revenue for the quarter came in at $1.7 billion versus the consensus estimate of $1.65 billion.

For earnings history and earnings-related data on Chemours (CC) click here.